AVBP (ArriVent BioPharma) Insider Ownership: 0.63 % (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AVBP ArriVent BioPharma Inc AVBP
14 GF Score
Price $29.21
! 1 Warning Sign
View Full Analysis

What is ArriVent BioPharma Insider Ownership?

ArriVent BioPharma AVBP -2.80% 14 Insider Ownership is 0.63 % as of Aug. 21, 2026. GuruFocus rates AVBP with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ArriVent BioPharma's insider ownership is 0.63%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ArriVent BioPharma's Institutional Ownership is 90.61%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ArriVent BioPharma's Float Percentage Of Total Shares Outstanding is 94.26%.

ArriVent BioPharma Insider Ownership Historical Data

* Premium members only.

The historical data trend for ArriVent BioPharma's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ArriVent BioPharma Insider Ownership Chart

ArriVent BioPharma Historical Data

The historical data trend for ArriVent BioPharma can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 0.79 0.72 0.72 0.72 0.70 0.70 0.70 0.66 0.63 0.63
AVBP
14GF Score
ArriVent BioPharma Inc AVBP
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ArriVent BioPharma Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 0.63 % mean?
ArriVent BioPharma (AVBP) has a Insider Ownership of 0.63 % as of Aug. 21, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on ArriVent BioPharma and its competitors.
Is ArriVent BioPharma's Insider Ownership too high?
ArriVent BioPharma's current Insider Ownership is 0.63 %. Overall, ArriVent BioPharma has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does ArriVent BioPharma's Insider Ownership compare to VIR and SEPN?
ArriVent BioPharma's Insider Ownership of 0.63 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on ArriVent BioPharma and its competitors. ArriVent BioPharma's current Insider Ownership is 0.63 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ArriVent BioPharma stock overvalued right now?
ArriVent BioPharma (AVBP) has a current Insider Ownership of 0.63 %. The current Insider Ownership is 0.63 %. ArriVent BioPharma's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For ArriVent BioPharma (AVBP), the current Insider Ownership is 0.63 % as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ArriVent BioPharma Business Description

Address 18 Campus Boulevard, Suite 100, Newtown Square, PA, USA, 19073
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. The company focuses on advancing its lead product candidate, firmonertinib, for the treatment of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC), and developing a pipeline of novel therapeutics, including next-generation antibody-drug conjugates such as ARR-217 (MRG007), with an initial focus on solid tumors.
14GF Score

Get the complete analysis for AVBP

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$29.21
Price